Celltrion
068270.KS
#772
Rank
โ‚ฌ24.40 B
Marketcap
117,84ย โ‚ฌ
Share price
1.34%
Change (1 day)
-1.72%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): 2,83ย โ‚ฌ

According to Celltrion 's latest financial reports the company's current EPS (TTM) is 2,84ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 2,77ย โ‚ฌ a decrease over its 2021 EPS that were of 3,29ย โ‚ฌ.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)2,83ย โ‚ฌ2.43%
20222,77ย โ‚ฌ-15.84%
20213,29ย โ‚ฌ12.77%
20202,91ย โ‚ฌ70.79%
20191,71ย โ‚ฌ15.63%
20181,48ย โ‚ฌ-33.13%
20172,21ย โ‚ฌ141.17%
20160,92ย โ‚ฌ8.28%
20150,85ย โ‚ฌ11.28%
20140,76ย โ‚ฌ16.37%
20130,65ย โ‚ฌ-67.42%
20122,00ย โ‚ฌ84.22%
20111,09ย โ‚ฌ62.13%
20100,67ย โ‚ฌ80.61%
20090,37ย โ‚ฌ-559.63%
2008-0,08081ย โ‚ฌ-123.16%
20070,35ย โ‚ฌ